FIELD: medicine.
SUBSTANCE: invention is implemented by single vaccination of the non-acute COPD patients against pneumococcal disease with the preparation Prevenar-13.
EFFECT: method is sage for the COPD patients; it is available for health care facilities, increases the clinical effectiveness in the patients suffering chronic obstructive pulmonary disease.
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF ACTIVATING FACTORS OF ANTIVIRAL PROTECTION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2591809C1 |
| METHOD OF ENHANCING NONSPECIFIC PROTECTION FACTORS ACTIVITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600838C1 |
| METHOD FOR PREVENTING ACUTE RESPIRATORY DISEASES OF THE UPPER RESPIRATORY TRACT IN CHILDREN AT INSULIN-DEPENDENT DIABETES MELLITUS | 2005 |
|
RU2294757C1 |
| METHOD FOR PREVENTING EXACERBATIONS OF BRONCHIAL ASTHMA | 2003 |
|
RU2252785C1 |
| METHOD OF ACUTE RESPIRATORY DISEASES PREVENTION DURING POSTVACCINAL PERIOD FOR CHILDREN SUFFERING FROM CHRONIC GLOMERULONEPHRITIS AND CHRONIC RENAL INSUFFICIENCY | 2005 |
|
RU2325182C2 |
| METHOD OF ACHIEVING PROLONGED CLINICAL REMISSION OF CHRONIC HPV INFECTION, MANIFESTING POINTED CONDYLOMA OF ANOGENITAL REGION | 2015 |
|
RU2595832C1 |
| IMMUNOBIOLOGICAL AGENT BASED ON RECOMBINANT PROTEIN FOR PREVENTING PNEUMOCOCCAL INFECTION | 2024 |
|
RU2823752C1 |
| METHOD OF POSTVACCINAL IMMUNITY TO VACCINE "PNEUMO-23" ANTIGENES TEST | 2006 |
|
RU2331074C2 |
| HYBRID PROTEIN VACCINE AGAINST PNEUMONIA CAUSED BY Streptococcus pneumoniae | 2012 |
|
RU2510281C2 |
| METHOD OF TREATING CHRONIC DISEASES OF EAR-NOSE-THROAT ORGANS WITH VIRAL, BACTERIAL, AND MIXED VIRAL-BACTERIAL ETIOLOGY IN HIV-INFECTED CHILDREN AND ADOLESCENTS | 2004 |
|
RU2305558C2 |
